VR-PAT for Pain and Anxiety Management During Pediatric Dermatologic Laser Procedures

Launched by NATIONWIDE CHILDREN'S HOSPITAL · Dec 8, 2022

Keywords

ClinConnect Summary

In this two-group crossover randomized clinical trial, patients will be randomly assigned to either the VR-PAT intervention group or control group (same VR google without game) at the first laser procedure and will then cross-over to the alternative group for the second laser procedure. Survey questions to assess pain and anxiety and control for confounding factors will be asked before and after each procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • dermatology patients (5+ years) who are undergoing first laser procedure at the Nationwide Children's Outpatient Laser
• • have a legal guardian present for patients less than 18 years old for the procedure (for informed consent)
• • can communicate orally
• Exclusion Criteria:
• • any wounds that may interfere with study procedures
• • usage of a diode laser (VR safety has not been established yet)
• • vision, hearing, or cognitive/motor impairments preventing valid administration of study measures
• • history of motion sickness, seizure disorder, dizziness, or migraine headaches precipitated by visual auras
• • minors in foster care
• • unable to communicate in English
• • pregnant women
• • prisoners

Trial Officials